UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011-2012, 2012-2013, and 2013-2014 Influenza Seasons

Clinical infectious diseases, 2018-08, Vol.67 (6), p.897-904

2018

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer

Cancer medicine (Malden, MA), 2021-10, Vol.10 (20), p.6971-6984

2021

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

Frontiers in oncology, 2023-01, Vol.12, p.1080729-1080729

2023

Link zum Volltext

Verfügbarkeit prüfen

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.73-83

2023

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib, a third‐generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real‐world efficacy and safety in advanced/recurrent non‐small cell lung carcinoma

Thoracic cancer, 2020-04, Vol.11 (4), p.935-942

2020

Link zum Volltext

Verfügbarkeit prüfen

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

Thoracic cancer, 2022-10, Vol.13 (19), p.2776-2785

2022

Link zum Volltext

Verfügbarkeit prüfen

Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed

Thoracic cancer, 2023-09, Vol.14 (25), p.2567-2578

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

Thoracic cancer, 2020-10, Vol.11 (10), p.2867-2876

2020

Link zum Volltext

Verfügbarkeit prüfen

A Case of Endobronchial Metastasis from TTF-1-positive Colon Cancer

The Journal of the Japan Society for Respiratory Endoscopy, 2020/07/25, Vol.42(4), pp.331-336

2020

Link zum Volltext

Verfügbarkeit prüfen

Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan

Vaccine, 2017-01, Vol.35 (4), p.687-693

2017

Link zum Volltext

Verfügbarkeit prüfen

MO3-3 Phase II study of S-1+CDDP with concurrent TRT followed by durvalumab for unresectable LA-NSCLC in Japan (SAMURAI)

Annals of oncology, 2023-11, Vol.34, p.S1396-S1396

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

Investigational new drugs, 2022-10, Vol.40 (5), p.1066-1079

2022

Link zum Volltext

Verfügbarkeit prüfen

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy

Oncology, 2021-08, Vol.99 (9), p.562-570

2021

Link zum Volltext

Verfügbarkeit prüfen

Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non-small Cell Lung Cancer

American journal of clinical oncology, 2020-03, Vol.43 (3), p.210

2020

Link zum Volltext

Verfügbarkeit prüfen

A Case of Rapid Malignant Brain Swelling Subacutely After Reperfusion Therapy for Internal Carotid Artery Occlusion

World neurosurgery, 2018-10, Vol.118, p.311-315

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factor of patients with advanced non-small cell lung cancer receiving best supportive care

Annals of oncology, 2017-10, Vol.28 Suppl 9, p.ix110

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer

Internal medicine (Tokyo, 1992), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Multicentric reticulohistiocytosis associated with ovarian cancer

Modern rheumatology, 2007-10, Vol.17 (5), p.422-425

2007

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

Therapeutic advances in medical oncology, 2021, Vol.13, p.1758835921998588-1758835921998588

2021

Link zum Volltext

Verfügbarkeit prüfen

気管支転移を生じたTTF-1陽性大腸癌の1例

気管支学, 2020/07/25, Vol.42(4), pp.331-336

2020

Link zum Volltext

Verfügbarkeit prüfen

Multicentric reticulohistiocytosis associated with ovarian cancer

Modern rheumatology, 2007-10, Vol.17 (5), p.422

2007

Link zum Volltext

Verfügbarkeit prüfen

Occurrence of organizing pneumonia after radiation therapy for postoperative breast cancer

Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2011-06, Vol.49 (6), p.458

2011

Link zum Volltext

Verfügbarkeit prüfen

Multicentric reticulohistiocytosis associated with ovarian cancer

Modern Rheumatology, 2007, Vol.17 (5), p.422-425

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(54)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011-2012, 2012-2013, and 2013-2014 Influenza Seasons

Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

Osimertinib, a third‐generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real‐world efficacy and safety in advanced/recurrent non‐small cell lung carcinoma

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

A Case of Endobronchial Metastasis from TTF-1-positive Colon Cancer

Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan

MO3-3 Phase II study of S-1+CDDP with concurrent TRT followed by durvalumab for unresectable LA-NSCLC in Japan (SAMURAI)

Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy

Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non-small Cell Lung Cancer

A Case of Rapid Malignant Brain Swelling Subacutely After Reperfusion Therapy for Internal Carotid Artery Occlusion

Prognostic factor of patients with advanced non-small cell lung cancer receiving best supportive care

Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer

Multicentric reticulohistiocytosis associated with ovarian cancer

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

気管支転移を生じたTTF-1陽性大腸癌の1例

Multicentric reticulohistiocytosis associated with ovarian cancer

Occurrence of organizing pneumonia after radiation therapy for postoperative breast cancer

Multicentric reticulohistiocytosis associated with ovarian cancer

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Suchergebnisse filtern